IBDEI0GL ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16643,1,3,0)
 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,16643,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,16643,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,16644,0)
 ;;=C78.7^^70^822^36
 ;;^UTILITY(U,$J,358.3,16644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16644,1,3,0)
 ;;=3^Secondary Malig Neop Liver & Intrahep BD
 ;;^UTILITY(U,$J,358.3,16644,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,16644,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,16645,0)
 ;;=C91.10^^70^822^4
 ;;^UTILITY(U,$J,358.3,16645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16645,1,3,0)
 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
 ;;^UTILITY(U,$J,358.3,16645,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,16645,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,16646,0)
 ;;=D46.9^^70^822^26
 ;;^UTILITY(U,$J,358.3,16646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16646,1,3,0)
 ;;=3^Myelodysplastic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,16646,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,16646,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,16647,0)
 ;;=C79.31^^70^822^33
 ;;^UTILITY(U,$J,358.3,16647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16647,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,16647,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,16647,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,16648,0)
 ;;=C79.32^^70^822^34
 ;;^UTILITY(U,$J,358.3,16648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16648,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,16648,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,16648,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,16649,0)
 ;;=G89.3^^70^822^29
 ;;^UTILITY(U,$J,358.3,16649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16649,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,16649,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,16649,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,16650,0)
 ;;=C79.82^^70^822^35
 ;;^UTILITY(U,$J,358.3,16650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16650,1,3,0)
 ;;=3^Secondary Malig Neop Genital Organs
 ;;^UTILITY(U,$J,358.3,16650,1,4,0)
 ;;=4^C79.82
 ;;^UTILITY(U,$J,358.3,16650,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,16651,0)
 ;;=I50.9^^70^823^7
 ;;^UTILITY(U,$J,358.3,16651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16651,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,16651,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,16651,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,16652,0)
 ;;=I73.9^^70^823^13
 ;;^UTILITY(U,$J,358.3,16652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16652,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16652,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,16652,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,16653,0)
 ;;=I35.0^^70^823^11
 ;;^UTILITY(U,$J,358.3,16653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16653,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,16653,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,16653,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,16654,0)
 ;;=I35.1^^70^823^10
 ;;^UTILITY(U,$J,358.3,16654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16654,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,16654,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,16654,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,16655,0)
 ;;=I35.2^^70^823^12
 ;;^UTILITY(U,$J,358.3,16655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16655,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,16655,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,16655,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,16656,0)
 ;;=I35.9^^70^823^9
 ;;^UTILITY(U,$J,358.3,16656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16656,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16656,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,16656,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,16657,0)
 ;;=I42.7^^70^823^3
 ;;^UTILITY(U,$J,358.3,16657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16657,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/External Agent
 ;;^UTILITY(U,$J,358.3,16657,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,16657,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,16658,0)
 ;;=I21.3^^70^823^14
 ;;^UTILITY(U,$J,358.3,16658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16658,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,16658,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,16658,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,16659,0)
 ;;=I25.5^^70^823^8
 ;;^UTILITY(U,$J,358.3,16659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16659,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,16659,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,16659,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,16660,0)
 ;;=I25.9^^70^823^6
 ;;^UTILITY(U,$J,358.3,16660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16660,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16660,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,16660,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,16661,0)
 ;;=I25.10^^70^823^2
 ;;^UTILITY(U,$J,358.3,16661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16661,1,3,0)
 ;;=3^Athscl Hrt Dis Ntv Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,16661,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16661,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16662,0)
 ;;=D64.9^^70^823^1
 ;;^UTILITY(U,$J,358.3,16662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16662,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16662,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,16662,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,16663,0)
 ;;=I42.9^^70^823^4
 ;;^UTILITY(U,$J,358.3,16663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16663,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,16663,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,16663,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,16664,0)
 ;;=I67.9^^70^823^5
 ;;^UTILITY(U,$J,358.3,16664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16664,1,3,0)
 ;;=3^Cerebrovascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16664,1,4,0)
 ;;=4^I67.9
 ;;^UTILITY(U,$J,358.3,16664,2)
 ;;=^5007389
 ;;^UTILITY(U,$J,358.3,16665,0)
 ;;=F04.^^70^824^2
 ;;^UTILITY(U,$J,358.3,16665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16665,1,3,0)
 ;;=3^Amnestic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16665,1,4,0)
 ;;=4^F04.
 ;;^UTILITY(U,$J,358.3,16665,2)
 ;;=^5003051
 ;;^UTILITY(U,$J,358.3,16666,0)
 ;;=F05.^^70^824^3
 ;;^UTILITY(U,$J,358.3,16666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16666,1,3,0)
 ;;=3^Delirium d/t Phsyiological Condition
 ;;^UTILITY(U,$J,358.3,16666,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,16666,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,16667,0)
 ;;=F06.8^^70^824^6
 ;;^UTILITY(U,$J,358.3,16667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16667,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,16667,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,16667,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,16668,0)
 ;;=F32.9^^70^824^5
 ;;^UTILITY(U,$J,358.3,16668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16668,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,16668,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,16668,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,16669,0)
 ;;=R41.82^^70^824^1
 ;;^UTILITY(U,$J,358.3,16669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16669,1,3,0)
 ;;=3^Altered Mental Status,Unspec
 ;;^UTILITY(U,$J,358.3,16669,1,4,0)
 ;;=4^R41.82
 ;;^UTILITY(U,$J,358.3,16669,2)
 ;;=^5019441
 ;;^UTILITY(U,$J,358.3,16670,0)
 ;;=R44.3^^70^824^4
 ;;^UTILITY(U,$J,358.3,16670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16670,1,3,0)
 ;;=3^Hallucinations,Unspec
 ;;^UTILITY(U,$J,358.3,16670,1,4,0)
 ;;=4^R44.3
 ;;^UTILITY(U,$J,358.3,16670,2)
 ;;=^5019458
 ;;^UTILITY(U,$J,358.3,16671,0)
 ;;=G20.^^70^825^7
 ;;^UTILITY(U,$J,358.3,16671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16671,1,3,0)
 ;;=3^Parkinson's Disease
